Please login to the form below

Not currently logged in
Email:
Password:

Neutec

This page shows the latest Neutec news and features for those working in and with pharma, biotech and healthcare.

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition. Will acquire Toplam Kalite for up to 300m Turkish lira. ... Japan's Takeda has reached a deal to buy a subsidiary of Turkish pharma company Neutec, giving it a firmer foothold in Turkey's $8.4bn

Latest news

  • Novartis delivers confident outlook despite Chiron costs

    In June, Novartis offered to buy UK firm, NeuTec Pharma for?

  • Keeping afloat

    The higher losses were driven by additional manufacturing and approval costs for Mycograb, one of two drugs NeuTec is developing. ... NeuTec also has Aurograb, a drug being developed to attack the hospital superbug MRSA.

  • High hopes

    The FDA, however, rejected the claims. NeuTec losses widen. Among smaller stocks biopharmaceutical company, NeuTec Pharma, reported increased first-half losses. ... NeuTec is also pinning its hopes on Aurograb, for the treatment of the hospital super bug

  • Stormy seas ahead

    NeuTec Pharma soars on bid talks. NeuTec Pharma, the AIM-listed biotech company, saw its share price rise astronomically by 422p to £10.80p after announcing it is in bid talks. ... Hopeful punters reckon a bid war could develop, pushing NeuTec's share

  • Rocky Road

    and Neutec Pharma going to Novartis for £305m a fortnight ago.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics